SIMRANJIT K KANG
Allopathic & Osteopathic Physicians|Family Medicine VANCOUVER, WA NPI 1275915977
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine WA Lumenis BE inc All categories
General Payments — all program years on this page
$2,283.47
- Category: General Payments
- Program years: PY2020–2024
- Record count: 27
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,586.41 across 10 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,586.41 | 10 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lumenis BE inc | $1,220.39 | 1 |
| ABBVIE INC. | $341.02 | 8 |
| Galderma Laboratories, L.P. | $25.00 | 1 |
By program year
Records — PY2024 (10)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1082155330 | Lumenis BE inc | $1,220.39 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104027885 | ABBVIE INC. | $5.87 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104027887 | ABBVIE INC. | $47.44 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104027889 | ABBVIE INC. | $106.14 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104027891 | ABBVIE INC. | $54.40 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104027893 | ABBVIE INC. | $19.93 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104027895 | ABBVIE INC. | $88.33 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104027897 | ABBVIE INC. | $4.52 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104027899 | ABBVIE INC. | $14.39 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145307453 | Galderma Laboratories, L.P. | $25.00 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.